
ESSA Pharma Inc.
NASDAQ:EPIX
1.63 (USD) • At close March 13, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | ESSA Pharma Inc. |
Symbool | EPIX |
Munteenheid | USD |
Prijs | 1.63 |
Beurswaarde | 72,353,337 |
Dividendpercentage | 0% |
52-weken bereik | 1.4 - 9.6 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. David Ross Parkinson M.D. |
Website | https://www.essapharma.com |
An error occurred while fetching data.
Over ESSA Pharma Inc.
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)